Company:  ATARA BIOTHERAPEUTICS, IN ... (ATRA)
Form Type:  8-K
Filing Date:  2/27/2020 
CIK:  0001604464 
Address:  611 GATEWAY BLVD
SUITE 900
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  650-278-8930 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$9.74  
Change: 
0.075 (0.78%)  
Trade Time: 
Jun 05  
Market Cap: 
$697.24M
Trade ATRA now with 

© 2020  
Description of Business
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company that is developing novel treatments for patients with cancer, autoimmune and viral diseases. We have several T-cell immunotherapies in clinical development and are progressing a next-generation allogeneic chimeric antigen receptor T-cell, or CAR T program.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits
    SIGNATURES
  EXHIBIT 99.1
    BALANCE SHEET
    INCOME STATEMENT